Georgios Vlasakakis

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Emergency Department

Iron Deficiency

Polycyclic Aromatic Hydrocarbons

Top Venues

Clinical and translational science

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Georgios Vlasakakis, Michael T McCabe, Yu Liu Ho, Geraldine Ferron-Brady, Paul Martin, Darren J Bentley, Catherine Ellis, Mary Antonysamy, Sandra A G Visser
Momelotinib: Mechanism of action, clinical, and translational science. Clinical and translational science 17 (8) (2024)
Yu Liu Ho, Peter D Gorycki, Geraldine Ferron-Brady, Paul Martin, Georgios Vlasakakis
Clinical assessment of momelotinib drug-drug interactions via CYP3A metabolism and transporters. Clinical and translational science 17 (4) (2024)
Yu Liu Ho, Peter D Gorycki, Geraldine Ferron-Brady, Paul Martin, Georgios Vlasakakis
Clinical assessment of momelotinib drug-drug interactions via CYP3A metabolism and transporters. Clinical and translational science 17 (4) (2024)
Yu Liu Ho, Peter D Gorycki, Geraldine Ferron-Brady, Paul Martin, Georgios Vlasakakis
Clinical assessment of momelotinib drug-drug interactions via CYP3A metabolism and transporters. Clinical and translational science 17 (4) (2024)
Georgios Vlasakakis, Michael T McCabe, Yu Liu Ho, Geraldine Ferron-Brady, Paul Martin, Darren J Bentley, Catherine Ellis, Mary Antonysamy, Sandra A G Visser
Momelotinib: Mechanism of action, clinical, and translational science. Clinical and translational science 17 (8) (2024)
Lina Keutzer, Huifang You, Ali Farnoud, Joakim Nyberg, Sebastian G Wicha, Gareth Maher-Edwards, Georgios Vlasakakis, Gita Khalili Moghaddam, Elin M Svensson, Michael Patrick Menden, Ulrika S H Simonsson, null On Behalf Of The Unite Tb Consortium
Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin. Pharmaceutics 14 (8) (2022)
Disala Fernando, Richard Dimelow, Ciara Gorey, Xinyi Zhu, Catherine Muya, Connie Parker, Wayne Wright, Sara Soleman, Sarah Walsh, Madelein Crause, Georgios Vlasakakis, William Guiney, Nicola Robertson, Marylise Bergeal, Yi Cui, Alexander W Krug, Iain Uings
Assessment of the safety, pharmacokinetics and pharmacodynamics of GSK3335065, an inhibitor of kynurenine monooxygenase, in a randomised placebo-controlled first-in-human study in healthy volunteers. British journal of clinical pharmacology (2021)
Georgios Vlasakakis, Antonella Napolitano, Ruth Barnard, Kim Brown, Jonathan Bullman, David Inman, Bart Keymeulen, David Lanham, Quentin Leirens, Alexander MacDonald, Enrica Mezzalana, Kevin Page, Minesh Patel, Caroline O Savage, Stefano Zamuner, Andre van Maurik
Target engagement and cellular fate of otelixizumab: a repeat dose escalation study of an anti-CD3ε mAb in new-onset type 1 diabetes mellitus patients. British journal of clinical pharmacology 85 (4) (2019)